- Markets
- Healthcare
- GUJTERC
GUJTERC
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Gujarat Terce Laboratories To Consider Proposal For Raising Of Funds
March 22 (Reuters) - Gujarat Terce Laboratories Ltd GUTL.BO:
TO CONSIDER PROPOSAL FOR RAISING OF FUNDS
Source text for Eikon: ID:nBSE5D77P5
Further company coverage: GUTL.BO
(([email protected];))
March 22 (Reuters) - Gujarat Terce Laboratories Ltd GUTL.BO:
TO CONSIDER PROPOSAL FOR RAISING OF FUNDS
Source text for Eikon: ID:nBSE5D77P5
Further company coverage: GUTL.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Guj. Terce Lab do?
Gujarat Terce Laboratories Limited, founded in 1985 in India, is a pharmaceutical company based in Gandhinagar, Gujarat.
Who are the competitors of Guj. Terce Lab?
Guj. Terce Lab major competitors are Roopa Industries, Shelter Pharma, Chandra Bhagat Pharm, Deccan Health Care, Walpar Nutritions, Bandaram Pharma Pack, Sandu Pharmaceutical. Market Cap of Guj. Terce Lab is ₹46 Crs. While the median market cap of its peers are ₹46 Crs.
Is Guj. Terce Lab financially stable compared to its competitors?
Guj. Terce Lab seems to be less financially stable compared to its competitors. Altman Z score of Guj. Terce Lab is 4.03 and is ranked 4 out of its 8 competitors.
Does Guj. Terce Lab pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Guj. Terce Lab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Guj. Terce Lab allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Guj. Terce Lab balance sheet?
Balance sheet of Guj. Terce Lab is strong. But short term working capital might become an issue for this company.
Is the profitablity of Guj. Terce Lab improving?
Yes, profit is increasing. The profit of Guj. Terce Lab is ₹2.96 Crs for TTM, ₹0.24 Crs for Mar 2024 and -₹1.67 Crs for Mar 2023.
Is the debt of Guj. Terce Lab increasing or decreasing?
The debt of Guj. Terce Lab is decreasing. Latest debt of Guj. Terce Lab is ₹3.11 Crs as of Sep-24. This is less than Mar-24 when it was ₹3.78 Crs.
Is Guj. Terce Lab stock expensive?
Guj. Terce Lab is not expensive. Latest PE of Guj. Terce Lab is 15.43, while 3 year average PE is 19.33. Also latest EV/EBITDA of Guj. Terce Lab is 12.81 while 3yr average is 50.43.
Has the share price of Guj. Terce Lab grown faster than its competition?
Guj. Terce Lab has given better returns compared to its competitors. Guj. Terce Lab has grown at ~-12.43% over the last 1yrs while peers have grown at a median rate of -21.11%
Is the promoter bullish about Guj. Terce Lab?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Guj. Terce Lab is 37.03% and last quarter promoter holding is 37.03%.
Are mutual funds buying/selling Guj. Terce Lab?
There is Insufficient data to gauge this.